← Back to headlines
Nuvation Bio Amends Protocol for Safusidenib Trials in Astrocytoma
Nuvation Bio Inc. has made amendments to the protocol for its Safusidenib trials, which are focused on treating astrocytoma.
2 Mar, 07:56 — 2 Mar, 07:56
Sources
Showing 1 of 1 sources
